Topics

Guinea

Ebola vaccine highly effective in Guinea trial

Ebola vaccine highly effective in Guinea trial

An experimental vaccine tested in more than 7,500 people in Guinea was highly protective against Ebola in a preliminary analysis. Results from the Phase III clinical trial were reported Friday in the medical journal The Lancet.  Organizations who sponsored the work, including the World Health Organization and Medecins Sans Frontiers, lauded the outcome of the work as a hopeful step in the fight against the devastating virus, which has killed more than 11,000 people in West Africa during the current outbreak and sickened more than 15,000 others. "For the first time ever, we received evidence of efficacy of a vaccine that will help [with] fighting Ebola,"...

Loading
70°